Company Filing History:
Years Active: 2021-2024
Title: Ashwini Balakrishnan: Innovator in Anti-ROR1 Antibodies
Introduction
Ashwini Balakrishnan is a notable inventor based in Seattle, WA. He has made significant contributions to the field of biotechnology, particularly in the development of anti-ROR1 antibodies. His work focuses on innovative solutions for diagnosing and treating diseases.
Latest Patents
Ashwini Balakrishnan holds 2 patents, with his latest patents centered around anti-ROR1 binding proteins. These patents detail the use of these proteins in immunohistochemical and diagnostic methods. The disclosure includes related kits and methods for utilizing these binding proteins, as well as treatment methods for subjects with diseases that are candidates for such therapies.
Career Highlights
Throughout his career, Ashwini has worked with esteemed institutions such as the Fred Hutchinson Cancer Center and the Fred Hutchinson Cancer Research Center. His experience in these organizations has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Ashwini has collaborated with notable colleagues, including Benjamin G. Hoffstrom and Julie Randolph-Habecker. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ashwini Balakrishnan's work in the field of anti-ROR1 antibodies exemplifies his commitment to advancing medical science. His contributions are paving the way for new diagnostic and therapeutic methods that could benefit many patients.